Guangzhou Repolarization Medical Technology Co
Guangzhou Repolarization Medical Technology Co., Ltd. is a biopharmaceutical company developing globally competitive innovative drugs, with a focus on targeted and immunotherapies. It benchmarks candidates against leading international pharmaceutical products and advances programs based on superior comparative data. Its MAX-4 targeted anticancer drug received FDA orphan drug designation.